TNSN02036A1 - Derives d'acide 3- heterocyclylpropano-hydroxamique nouveaux, et compositions les contenant. - Google Patents
Derives d'acide 3- heterocyclylpropano-hydroxamique nouveaux, et compositions les contenant.Info
- Publication number
- TNSN02036A1 TNSN02036A1 TNTNSN02036A TNSN02036A TNSN02036A1 TN SN02036 A1 TNSN02036 A1 TN SN02036A1 TN TNSN02036 A TNTNSN02036 A TN TNSN02036A TN SN02036 A TNSN02036 A TN SN02036A TN SN02036 A1 TNSN02036 A1 TN SN02036A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compositions containing
- heterocyclylpropano
- new
- acid derivatives
- hydroxamic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0108102.5A GB0108102D0 (en) | 2001-03-30 | 2001-03-30 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN02036A1 true TNSN02036A1 (fr) | 2005-12-23 |
Family
ID=9911984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN02036A TNSN02036A1 (fr) | 2001-03-30 | 2002-03-29 | Derives d'acide 3- heterocyclylpropano-hydroxamique nouveaux, et compositions les contenant. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1373264B1 (ja) |
JP (1) | JP2004524365A (ja) |
AP (1) | AP2002002466A0 (ja) |
AT (1) | ATE285409T1 (ja) |
BR (1) | BR0208499A (ja) |
CA (1) | CA2442481A1 (ja) |
DE (1) | DE60202358T2 (ja) |
ES (1) | ES2232740T3 (ja) |
GB (1) | GB0108102D0 (ja) |
GT (1) | GT200200062A (ja) |
MX (1) | MXPA03008944A (ja) |
PA (1) | PA8542201A1 (ja) |
PE (1) | PE20021045A1 (ja) |
TN (1) | TNSN02036A1 (ja) |
UY (1) | UY27236A1 (ja) |
WO (1) | WO2002079200A1 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200508298B (en) * | 2003-04-11 | 2007-01-31 | Ptc Therapeutics Inc | 1,2,4-oxadiazole benzoic acid compounds |
EP1694670A1 (en) * | 2003-12-16 | 2006-08-30 | GPC Biotech AG | Pyrazine derivatives as effective compounds against infectious diseases |
DE102004003812A1 (de) * | 2004-01-25 | 2005-08-11 | Aventis Pharma Deutschland Gmbh | Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel |
US7319108B2 (en) | 2004-01-25 | 2008-01-15 | Sanofi-Aventis Deutschland Gmbh | Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
US7642354B2 (en) | 2004-04-13 | 2010-01-05 | Icagen, Inc. | Polycyclic pyrazines as potassium ion channel modulators |
SG10201809390QA (en) | 2005-05-10 | 2018-11-29 | Incyte Holdings Corp | Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
EP1971583B1 (en) | 2005-12-20 | 2015-03-25 | Incyte Corporation | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
CL2007002650A1 (es) | 2006-09-19 | 2008-02-08 | Incyte Corp | Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras. |
JP5319532B2 (ja) | 2006-09-19 | 2013-10-16 | インサイト・コーポレイション | インドールアミン2,3−ジオキシゲナーゼのモジュレーターとしてのn−ヒドロキシアミジノヘテロサイクル |
DE102007025718A1 (de) | 2007-06-01 | 2008-12-04 | Merck Patent Gmbh | Pyridazinonderivate |
CN102164902B (zh) | 2008-07-08 | 2014-07-23 | 因塞特公司 | 作为吲哚胺2,3-双加氧酶的抑制剂的1,2,5-噁二唑 |
WO2010100142A1 (en) | 2009-03-03 | 2010-09-10 | Merck Serono S.A. | Oxazole pyridine derivatives useful as s1p1 receptor agonists |
AR098343A1 (es) | 2013-11-08 | 2016-05-26 | Incyte Holdings Corp | Proceso para la síntesis de un inhibidor de indolamina 2,3-dioxigenasa |
TW201620887A (zh) * | 2014-01-10 | 2016-06-16 | 葛蘭素史克智慧財產(第二)有限公司 | 化合物及方法 |
TWI695717B (zh) | 2014-03-06 | 2020-06-11 | 美商 Ptc 治療公司 | 1,2,4-二唑苯甲酸之鹽及醫藥組合物 |
JP2018531975A (ja) | 2015-10-30 | 2018-11-01 | ピーティーシー セラピューティクス,インコーポレーテッド | てんかんの治療方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9725782D0 (en) * | 1997-12-05 | 1998-02-04 | Pfizer Ltd | Therapeutic agents |
AU3196200A (en) * | 1999-03-26 | 2000-10-16 | Shionogi & Co., Ltd. | Beta-amino acid derivatives |
GB9930570D0 (en) * | 1999-12-23 | 2000-02-16 | Pfizer Ltd | Therapy |
-
2001
- 2001-03-30 GB GBGB0108102.5A patent/GB0108102D0/en not_active Ceased
-
2002
- 2002-03-08 AT AT02713078T patent/ATE285409T1/de not_active IP Right Cessation
- 2002-03-08 CA CA002442481A patent/CA2442481A1/en not_active Abandoned
- 2002-03-08 JP JP2002577825A patent/JP2004524365A/ja not_active Ceased
- 2002-03-08 WO PCT/IB2002/000699 patent/WO2002079200A1/en active IP Right Grant
- 2002-03-08 ES ES02713078T patent/ES2232740T3/es not_active Expired - Lifetime
- 2002-03-08 MX MXPA03008944A patent/MXPA03008944A/es active IP Right Grant
- 2002-03-08 EP EP02713078A patent/EP1373264B1/en not_active Expired - Lifetime
- 2002-03-08 DE DE60202358T patent/DE60202358T2/de not_active Expired - Fee Related
- 2002-03-08 BR BR0208499-6A patent/BR0208499A/pt not_active IP Right Cessation
- 2002-03-25 PE PE2002000235A patent/PE20021045A1/es not_active Application Discontinuation
- 2002-03-26 GT GT200200062A patent/GT200200062A/es unknown
- 2002-03-27 UY UY27236A patent/UY27236A1/es not_active Application Discontinuation
- 2002-03-27 PA PA20028542201A patent/PA8542201A1/es unknown
- 2002-03-28 AP APAP/P/2002/002466A patent/AP2002002466A0/en unknown
- 2002-03-29 TN TNTNSN02036A patent/TNSN02036A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
GB0108102D0 (en) | 2001-05-23 |
ES2232740T3 (es) | 2005-06-01 |
PE20021045A1 (es) | 2002-11-19 |
EP1373264B1 (en) | 2004-12-22 |
WO2002079200A1 (en) | 2002-10-10 |
BR0208499A (pt) | 2004-04-20 |
DE60202358T2 (de) | 2005-12-08 |
PA8542201A1 (es) | 2002-10-28 |
DE60202358D1 (en) | 2005-01-27 |
UY27236A1 (es) | 2002-11-29 |
GT200200062A (es) | 2003-11-15 |
EP1373264A1 (en) | 2004-01-02 |
AP2002002466A0 (en) | 2002-06-30 |
CA2442481A1 (en) | 2002-10-10 |
MXPA03008944A (es) | 2003-12-08 |
ATE285409T1 (de) | 2005-01-15 |
JP2004524365A (ja) | 2004-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN02036A1 (fr) | Derives d'acide 3- heterocyclylpropano-hydroxamique nouveaux, et compositions les contenant. | |
TNSN99106A1 (fr) | Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN00104A1 (fr) | Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN00036A1 (fr) | Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN97145A1 (fr) | Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99073A1 (fr) | Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99169A1 (fr) | Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN00092A1 (fr) | Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN97192A1 (fr) | Derives de pyrimidine bicycliques condenses, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99236A1 (fr) | Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN00065A1 (fr) | Derives nouveaux de pyrimidine inhibiteurs de sorbitol- deshydrogenase, leur procede de preparation et compositions pharmaceutiques les contenant. | |
TNSN98019A1 (fr) | Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26697A1 (fr) | Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant | |
TNSN01102A1 (fr) | Derives de pyrazole nouveaux, procede pour leur preparation et compositions les contenant. | |
TNSN98022A1 (fr) | DERIVES DE N-HYDROXY-β-SULFONYLPROPIONAMIDE, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT. | |
TNSN98150A1 (fr) | Derives d'acides aryloxyarylsulfonylaminohydroxamiques ; procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99031A1 (fr) | Composes heterocycliques nouveaux inhibiteurs de romatases, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99110A1 (fr) | Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN02021A1 (fr) | Derives de benzimidazole nouveaux, et compositions les contenant | |
TNSN98194A1 (fr) | Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99156A1 (fr) | Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99155A1 (fr) | 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99253A1 (fr) | Composes chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant. | |
TNSN98036A1 (fr) | Derives d'acide hexanoique nouveaux | |
TNSN98066A1 (fr) | Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |